Amphastar Pharmaceuticals
World Rank (Aug-2026)
9,798
Market Cap (Aug-2026)
0.889 Billion USD
World Rank (Jan-05-2024)
4,332
Market Cap (Jan-05-2024)
3.040 Billion USD
World Rank (Jul-30-2023)
4,422
Market Cap (Jul-30-2023)
2.937 Billion USD
World Rank (Dec-25-2022)
6,890
Market Cap (Dec-25-2022)
1.386 Billion USD
World Rank (Jan-07-2022)
8,516
Market Cap (Jan-07-2022)
1.20 Billion USD
Annual Revenue in USD
498 Million USD
Annual Net Income in USD
91 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Amphastar Pharmaceuticals is a Specialty Pharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products. It produce over 20 commercial products while continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. The headquarters is in USA.
Company Website